scispace - formally typeset
S

Seema Sethi

Researcher at Wayne State University

Publications -  59
Citations -  3157

Seema Sethi is an academic researcher from Wayne State University. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 30, co-authored 59 publications receiving 2895 citations.

Papers
More filters
Journal ArticleDOI

Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells.

TL;DR: In this article, a mechanistic understanding of prostate cancer recurrence and metastasis is proposed, which is closely linked with the biology of prostate stem cells or cancer-initiating cells that is reminiscent of the acquisition of Epithelial to Mesenchymal Transition (EMT) phenotype.
Journal ArticleDOI

Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM

TL;DR: The results suggest that the loss of let-7 mediated increased expression of EZH2 contributes to PCa aggressiveness, which could be attenuated by BR-DIM treatment, and thus BR- DIM is likely to have clinical impact.
Journal ArticleDOI

Phosphoglucose Isomerase/Autocrine Motility Factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells

TL;DR: A role ofmiR-200s in PGI/AMF-induced EMT is suggested and approaches for upregulation of miR- 200s could be a novel therapeutic strategy for the treatment of highly invasive breast cancer.
Journal Article

Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis.

TL;DR: Variation in the aberrant expression patterns at the invasive tumor front indicates the role of EMT markers in tumor invasion and suggests that Notch-1 could play a role in PCa bone metastasis.
Journal ArticleDOI

Hypoxia-Induced Aggressiveness of Pancreatic Cancer Cells Is Due to Increased Expression of VEGF, IL-6 and miR-21, Which Can Be Attenuated by CDF Treatment

TL;DR: It is shown for the first time that hypoxia leads to increased expression of VEGF, IL-6, and CSC signature genes Nanog, Oct4 and EZH2 consistent with increased cell migration/invasion and angiogenesis, and the formation of pancreatospheres, and thus CDF could become a novel, and effective anti-tumor agent for PC therapy.